Pharmaceutical inhibition of FABP4 reversed the effects of the adipocyte co-culture, and conversely when FABP4 was overexpressed in colon cancer cells, significant increases in metastases were observed in vivo. The gene discussed is FABP4; the disease is malignant colon neoplasm.